JOHN F AFFLECK-GRAVES
CIK 1297755 · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.71M
Companies
2
Total Filings
40
Lifetime Open-Market Net
$88.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRCE | Director | 21,731 | $78.52 | $1.71M | $88.7K | 29 | 2026-06-05 |
| Hi-Crush Inc. (HCLP) Delisted | Director | 87,320 | — | — | $0 | 11 | 2019-01-16 |
Recent Filings · Page 3 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-04 | SRCE | Grant (A) | +1,646 | $80.8K | EDGAR |
| 2021-02-03 | SRCE | Grant (A) | +301 | $12.0K | EDGAR |
| 2020-11-04 | SRCE | Grant (A) | +361 | $12.0K | EDGAR |
| 2020-08-03 | SRCE | Grant (A) | +397 | $13.5K | EDGAR |
| 2020-06-03 | SRCE | Grant (A) | +2,004 | $70.5K | EDGAR |
| 2020-02-06 | SRCE | Grant (A) | +226 | $11.0K | EDGAR |
| 2019-11-06 | SRCE | Grant (A) | +38 | $2.0K | EDGAR |
| 2019-08-30 | SRCE | Grant (A) | +1,097 | $48.9K | EDGAR |
| 2019-08-27 | SRCE | Buy (P) | +2,000 | $88.7K | EDGAR |
| 2019-01-16 | Hi-Crush Inc. (HCLP) Delisted | Grant (A) | +20,305 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.